Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Amazon Natural (AZNT) -- Ignore unavailable to you. Want to Upgrade?

To: jhild who wrote (2188)	8/27/1998 3:40:00 PM
From: bmart	Read Replies (1) \| Respond to of 26163

Mr. Jhild, What is the status of evaluating the value of Dr. Lorrichio's intellectual properties? Are the financials audited? Now that the company has made the transition from a R & D company to a company generating revenues, how will that be reflected in those financials? What of talks with other companies, how are they proceeding? Monsanto? Can you expound? The company has gone to this extent to reach shareholder value. If there were no illegal shares in the AZNT market we would not have the need to even discuss the topic. Who's accounts are frozen and why? Have those in question been served? How much time do they have before they must cover by buying shares in the open market? RB

To: jhild who wrote (2188)	8/27/1998 3:40:00 PM
From: KCsunshine	Read Replies (2) \| Respond to of 26163

jhild - How has this increased its market capitalization on such anemic volume? Please offer some suggestions. To date we have been informed that a newsletter through email and evil maker of market manipulation has quintupled this securities worth, do you subscribe to these theorums? I have been attacked and had numerous insinuations made since I first arrived, does your traveling roadshow ever cease these attacks, insinuations and lies? Please you wish a civil discourse, yet your minionsunderstand civility as well as they understand diligence. Where have I mislead as you insinuated? Do not stray from course, please answer your callous barb with fact or leave. You attack and then change topic, well sir, answer. Where have I mislead or will you apologize for your baseless accusation? Then we could, perhaps, dialog about the fundamentals of the short squeeze or the company. KC